The study reflects the importance of including multiple biomarkers for diagnostic and treatment decisions associated with pneumonia, IVD industry experts said.
The Australian Red Cross Blood Service will use the Alinity s System to process its blood tests and improve lab automation.
The developers anticipate that their new approach may enable noninvasive and continuous monitoring of glucose, lactate, and other clinical parameters.
Aalto sells raw materials for in vitro diagnostics including purified human proteins, monoclonal and polyclonal antibodies, and viral antigens.
The firm said that a new R&D plant will enable it to develop non-core testing applications that allow it to enter new markets, such as veterinary diagnostics.
The device is intended for preparation of stool samples and use with Buhlmann's Fcal Turbo calprotectin test.
The solutions are solutions for both clinical chemistry and immunoassay platforms and are meant to help labs run tests faster on less equipment and automate manual tasks.
A JAMA study found that low-value diagnostic tests are common in inpatient settings, and machine learning systems can be used to identify those tests and reduce their overutilization.
Roche Diagnostics got the nod for its Elecsys Anti-HAV II test for the detection of total antibodies — IgG and IgM — to the hepatitis A virus.
A recent study from UCSF suggests Abbott's blood-based i-Stat Alinity device may be able to identify TBI that isn't found by a CT scan.
Sysmex alleges multiple Beckman Coulter analyzers of infringing two patents covering technology for sensing blood or fluid samples.
The partners plan to validate the accuracy, effectiveness, and clinical implications of Group K's MultiNostic liver function test, which is pending FDA clearance.
The merger is aimed at expanding Salveo’s diagnostics capabilities and improving communication with providers and patients.
Representatives of NBs said they are adding capacity to allow oversight of the anticipated wave of submissions before the new IVD Regulation comes into force in three years.
The combined company will offer laboratory testing and digital technologies for diagnosing and managing lupus, multiple sclerosis, and other autoimmune diseases.
A study by clinicians at St. Louis's Barnes-Jewish Hospital found that staff overrode alerts designed to warn of unnecessary lab testing roughly half the time.
The first tests to be made available through the collaboration will be for Lyme disease and food sensitivity, leveraging PerkinElmer's expertise.
The firm said that its molecular diagnostics sales growth in the quarter was negatively impacted by non-governmental organization purchasing patterns in Africa.
Based in Austria, EuroLyser develops point-of-care testing devices and kits. ArchiMed also acquired EuroLab, EuroLyser's main distributor.
The new list comprises 122 test categories — 46 general IVDs, 69 IVDs for specific diseases, and seven test categories for screening blood donations.